THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsRandomized sham-controlled trial

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Depression scores improved more with active deep rTMS than with sham stimulation over four weeks. A possible relationship with baseline triglycerides is exploratory and is not ready to guide treatment decisions.

Liu L, Wang J, Wu Z, Wang J, Li N, Wang M.
Clinical EEG and neuroscience · Publication date: 2026-09-10
Added to site: 2026-09-11
DOI: 10.1177/15500594261487817

First-publication date from the authoritative indexed record.

Modalities
TMS
Clinical focus
Depression, Personalization
Population
Patients with moderate-to-severe depressive disorder
Sample
80 participants; 40 active and 40 sham
Intervention / method
Twenty high-frequency deep-rTMS sessions over four weeks
Comparator
Sham stimulation

Clinician summary

The primary HAMD-17 change favored active treatment. Higher baseline fasting triglycerides were associated with greater improvement, with a stronger association in the active arm.

How to interpret the findings

The abstract does not provide effect sizes, remission or response rates, adverse-event counts, follow-up beyond treatment, or external validation of triglycerides as a predictive biomarker.

Equipment and disclosures

High-frequency deep rTMS was described; coil design and commercial system were not verified from the abstract.

Funding and competing-interest disclosures were not verified from the reviewed abstract.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-09-11

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.